Clinical Trial Update: A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

Phase 1/2 study of AZD0466 in advanced Non-Hodgkin Lymphoma was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• AZD0466

Snippet

Sponsor: AstraZeneca | Conditions: Non-Hodgkin Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2025-01-07